gnr-038
Peptideexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Mar 10, 2020 (NCT04557319)
Timeline
Indications
Studied for
Mechanism of action
- Plasma protease C1 inhibitorINHIBITOR
SERPING1 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04898309 | Phase 2/Phase 3 (Phase 3) | Dec 1, 2021 | AO GENERIUM |
| NCT04557319 | Phase 1 | Mar 10, 2020 | AO GENERIUM |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AO GENERIUM | For profit | 2 | 2 | 2 | 2020 |
1 organizations
Page 1 / 1